AML-063: A Randomized, Double-Blind, Placebo-Controlled Study of Venetoclax with Azacitidine Versus Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia Ineligible for Intensive Therapy-Viale-A
暂无分享,去创建一个
J. Esteve | H. Döhner | Wan-Jen Hong | M. Konopleva | G. Juliusson | C. Dinardo | Jacqueline S. Garcia | Jianxiang Wang | R. Hájek | P. Fenaux | A. Wei | K. Porkka | K. Pratz | W. Fiedler | C. Récher | Á. Illés | E. Koller | R. Vrhovac | A. Schuh | V. Havelange | M. Thirman | V. Pullarkat | S. Yeh | J. Jang | M. Ozcan | Kazuhito Yamamoto | O. Wolach | B. Jonas | J. Potluri | A. Olivieri | V. Vorobyev | Ying Zhou | Wan-Jen Hong | W. Hong | V. Vorobyev